Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming

Cited by (1,000)

Items 801–900 of 1,000

1. Paxlovid accelerates cartilage degeneration and senescence through activating endoplasmic reticulum stress and interfering redox homeostasis
   Keyu Kong, Yongyun Chang, Hua Qiao, Chen Zhao, Xuzhuo Chen, Kewei Rong, Pu Zhang, Minghao Jin, Jingwei Zhang, Huiwu Li et al. · 2022 · Journal of Translational Medicine
2. Metabolic reprogramming by histone deacetylase inhibition preferentially targets NRF2-activated tumors
   Dimitris Karagiannis, Warren Wu, Albert Mao Li, Makiko Hayashi, Xiao Chen, Michaela Yip, Vaibhav S. Mangipudy, Xinjing Xu, Francisco J. Sánchez Rivera, Yadira M. Soto‐Feliciano et al. · 2023 · Cell Reports
3. NRF2 Signaling Pathway in Chemo/Radio/Immuno-Therapy Resistance of Lung Cancer: Looking Beyond the Tip of the Iceberg
   Sri Vidya Ramisetti, Tapas Patra, Vinayak Munirathnam, Jyothi Venkat Sainath, Durgadevi Veeraiyan, Akhileshwar Namani · 2024 · Archivos de Bronconeumología
4. NRF2 Mediates Neuroblastoma Proliferation and Resistance to Retinoic Acid Cytotoxicity in a Model of In Vitro Neuronal Differentiation
   Vítor de Miranda Ramos, Alfeu Zanotto‐Filho, Matheus Augusto de Bittencourt Pasquali, Karina Klafke, Juciano Gasparotto, Peter Robert Dunkley, Daniel Pens Gelain, José Cláudio Fonseca Moreira · 2015 · Molecular Neurobiology
5. Small Maf deficiency recapitulates the liver phenotypes of Nrf1‐ and Nrf2‐deficient mice
   Fumiki Katsuoka, Hiromi Yamazaki, Masayuki P. Yamamoto · 2016 · Genes to Cells
6. Lactate dehydrogenase C is required for the protein expression of a sperm-specific isoform of lactate dehydrogenase A
   Mina Dodo, Hiroshi Kitamura, Hiroki Shima, Daisuke Saigusa, Sisca Meida Wati, Nao Ota, Fumiki Katsuoka, Hatsune Chiba, Hiroaki Okae, Takahiro Arima et al. · 2018 · The Journal of Biochemistry
7. NRF2 Dysregulation in Hepatocellular Carcinoma and Ischemia: A Cohort Study and Laboratory Investigation
   Etay Ziv, Yiru Zhang, Luke Kelly, Ines Nikolovski, Franz Edward Boas, Joseph Patrick Erinjeri, Li‐Qun Cai, Elena Nadia Petre, Lynn A. Brody, Anne M. Covey et al. · 2020 · Radiology
8. An Overview of Therapeutic Targeting of Nrf2 Signaling Pathway in Rheumatoid Arthritis
   Sarmistha Saha · 2024 · ACS Omega
9. Oxidative complexity: The role of ROS in the tumor environment and therapeutic implications
   Ting Shen, Yutong Wang, Linmao Cheng, Ann M. Bode, Ya Gao, Shuntong Zhang, Xue Chen, Xiangjian Luo · 2025 · Bioorganic & Medicinal Chemistry
10. Repression of Nrf2 enhances antitumor effect of 5-fluorouracil and gemcitabine on cholangiocarcinoma cells
    Papavee Samatiwat, Auemduan Prawan, Laddawan Senggunprai, Veerapol Kukongviriyapan · 2015 · Naunyn-Schmiedeberg s Archives of Pharmacology
11. Nuclear factor erythroid 2 (NF-E2)-related factor 2 (Nrf2) in non-small cell lung cancer
    Zhi Zeng, Ziyao Wang, Yukun Li, Dongmei Ye, Juan Zeng, Jiali Hu, Pi-feng Chen, Jiao Xiao, Juan Zou, Zhenhua Li · 2020 · Life Sciences
12. 13C Metabolic Flux Analysis Indicates Endothelial Cells Attenuate Metabolic Perturbations by Modulating TCA Activity
    Bilal Moiz, Jonathan Garcia, Sarah E. Basehore, Angela Sun, Andrew Li, Surya Padmanabhan, Kaitlyn Albus, Cholsoon Jang, Ganesh Sriram, Alisa Morss Clyne · 2021 · Metabolites
13. SLC1A5 co-expression with TALDO1 associates with endocrine therapy failure in estrogen receptor-positive breast cancer
    Lutfi H. Alfarsi, Rokaya El Ansari, Madeleine L. Craze, Omar J. Mohammed, Brendah K. Masisi, Ian Ogilvie Ellis, Emad A. Rakha, Andrew R. Green · 2021 · Breast Cancer Research and Treatment
14. Electrolyzed hydrogen-rich water for oxidative stress suppression and improvement of insulin resistance: a multicenter prospective double-blind randomized control trial
    Susumu Ogawa, Yusuke Ohsaki, Manami Shimizu, Kazuhiro Nako, Masashi Okamura, Shigeru Kabayama, Kiyoshi Tabata, Yasuhisa Tanaka, Sadayoshi Ito · 2021 · Diabetology International
15. Glutamine Modulates Expression and Function of Glucose 6-Phosphate Dehydrogenase via NRF2 in Colon Cancer Cells
    Ibrahim H. Polat, Míriam Tarrado‐Castellarnau, Adrián Benito, Claudia Hernández-Carro, Josep J. Centelles, Silvia Marín, Marta Cascante · 2021 · Antioxidants
16. NRF2 pathway activation attenuates ageing-related renal phenotypes due to α-klotho deficiency
    Mingyue Zhao, Shohei Murakami, Daisuke Matsumaru, Takeshi Kawauchi, Yo‐ichi Nabeshima, Hozumi Motohashi · 2022 · The Journal of Biochemistry
17. Erythritol synthesis is elevated in response to oxidative stress and regulated by the non-oxidative pentose phosphate pathway in A549 cells
    Semira R. Ortiz, Alexander Heinz, Karsten Hiller, Martha S. Field · 2022 · Frontiers in Nutrition
18. Ferroptosis model system by the re-expression of BACH1
    Riko Irikura, Hironari Nishizawa, Kazuma Nakajima, Mie Yamanaka, Guan Chen, Kozo Tanaka, Masafumi Onodera, Mitsuyo Matsumoto, Kazuhiko Igarashi · 2023 · The Journal of Biochemistry
19. Adaptive and Constitutive Activations of Malic Enzymes Confer Liver Cancer Multilayered Protection Against Reactive Oxygen Species
    Derek Lee, Misty Shuo Zhang, Felice Ho‐Ching Tsang, Macus Hao‐Ran Bao, Mingjing Xu, Robin Kit‐Ho Lai, David Kung‐Chun Chiu, Aki Pui‐Wah Tse, Cheuk‐Ting Law, Cerise Yuen‐Ki Chan et al. · 2021 · Hepatology
20. Dexmedetomidine Relieves Neuropathic Pain in Rats With Chronic Constriction Injury via the Keap1–Nrf2 Pathway
    Yatao Liu, Wei Liu, Xiaoqing Wang, Zhan-Hai Wan, Yongqiang Liu, Meng-Jie Zhang · 2021 · Frontiers in Cell and Developmental Biology
21. Emerging Therapeutic Targets in Oncologic Photodynamic Therapy
    Gina Manda, Mihail Eugen Hinescu, Ionela Victoria Neagoe, L.F. Vieira Ferreira, Rica Boscencu, Paul R. Vasos, Selma Huveyda Basaga, Antonio Cuadrado · 2019 · Current Pharmaceutical Design
22. Glycine Decarboxylase (GLDC) Plays a Crucial Role in Regulating Energy Metabolism, Invasion, Metastasis and Immune Escape for Prostate Cancer
    Mingkun Chen, Zhuoyu Xiao, Zhipeng Huang, Kangyi Xue, Hui Xia, Jiawei Zhou, De-Ying Liao, Zhi-Jian Liang, Xie Xiao, Qing-Zhu Wei et al. · 2023 · International Journal of Biological Sciences
23. Role of amino acids in the regulation of hepatic gluconeogenesis and lipogenesis in metabolic dysfunctionassociated steatotic liver disease
    Eiji Kakazu, Masaaki Mino, Tatsuya Kanto · 2025 · Clinical and Molecular Hepatology
24. Altered NRF2 signalling in systemic redox imbalance: Insights from non-communicable diseases
    Monika A. Jakubowska, Vera Marisa Costa, Wojciech Krzeptowski, Pia Pužar Dominkuš, Marlene Santos, Birsen Can Demirdöğen, Şermin Genç, Ioannis P. Trougakos, Katja M. Kanninen, Brigitte M. Winklhofer‐Roob et al. · 2025 · Redox Biology
25. African-American esophageal squamous cell carcinoma expression profile reveals dysregulation of stress response and detox networks
    Hayriye Verda Erkizan, Kory R. Johnson, Svetlana D. Ghimbovschi, Deepa Karkera, Gregory D. Trachiotis, Houtan Adib, Eric P. Hoffman, Robert G. Wadleigh · 2017 · BMC Cancer
26. Side Chain Optimization Remarkably Enhances the in Vivo Stability of 18 F-Labeled Glutamine for Tumor Imaging
    Junyi Chen, Cong Li, Hanyu Hong, Hui Liu, Chunhong Wang, Mengxin Xu, Yuxiang Han, Zhibo Liu · 2019 · Molecular Pharmaceutics
27. Expression of TXNIP is associated with angiogenesis and postoperative relapse of conventional renal cell carcinoma
    Máté Mészáros, Maria Viktorovna Yusenko, Lilla Domonkos, Lehel Péterfi, Gyula Kovács, Dániel Bányai · 2021 · Scientific Reports
28. Revisiting therapeutic strategies for ovarian cancer by focusing on redox homeostasis (Review)
    Hiroshi Kobayashi, Shogo Imanaka, Hiroshi Shigetomi · 2022 · Oncology Letters
29. Mechanisms used by cancer cells to tolerate drug-induced replication stress
    Hendrika A. Segeren, Bart Westendorp · 2022 · Cancer Letters
30. Pros and cons of NRF2 activation as adjunctive therapy in rheumatoid arthritis
    Gina Manda, Elena Milanesi, Şermin Genç, Cristina Mariana Niculite, Ionela Victoria Neagoe, Bora Tastan, Elena Mihaela Dragnea, Antonio Cuadrado · 2022 · Free Radical Biology and Medicine
31. Complex role of HIF in cancer: the known, the unknown, and the unexpected
    Eric L. Huang, Patricia D.B. Tiburcio, Hyunsung Choi · 2014 · Hypoxia
32. Emerging approaches to target tumor metabolism
    Sarah J. Ross, Susan E. Critchlow · 2014 · Current Opinion in Pharmacology
33. Procyanidins from Cinnamomi Cortex promote proteasome-independent degradation of nuclear Nrf2 through phosphorylation of insulin-like growth factor-1 receptor in A549 cells
    Tomokazu Ohnuma, Kazuya Sakamoto, Asumi Shinoda, Chiaki Takagi, Shoko Ohno, Takahito Nishiyama, Kenichiro Ogura, Akira Hiratsuka · 2017 · Archives of Biochemistry and Biophysics
34. BET‐ting on Nrf2: How Nrf2 Signaling can Influence the Therapeutic Activities of BET Protein Inhibitors
    Nirmalya Chatterjee, Dirk Bohmann · 2018 · BioEssays
35. Metformin reverses the resistance mechanism of lung adenocarcinoma cells that knocks down the Nrf2 gene
    Jiacui Zhang, Keping Jiao, Jing Liu, Yu Xia · 2018 · Oncology Letters
36. Protective Effects of Rice Peptide Oryza Peptide-P60 against Oxidative Injury through Activation of Nrf2 Signaling Pathway In Vitro and In Vivo
    Chie Moritani, Kayoko Kawakami, Hiroshi Shimoda, Tadashi Hatanaka, Etsuko Suzaki, Seiji Tsuboi · 2020 · ACS Omega
37. Altered mitochondrial fusion drives defensive glutathione synthesis in cells able to switch to glycolytic ATP production
    David A. Patten, Shawn McGuirk, Ujval Anilkumar, Ghadi Antoun, Karan Gandhi, Gaganvir Parmar, Mohamed Ariff Iqbal, Jacob Wong, Richard B. Richardson, Julie St‐Pierre et al. · 2020 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
38. Nrf2 in Neoplastic and Non-Neoplastic Liver Diseases
    Claudia Orrù, Silvia Giordano, Amedeo Columbano · 2020 · Cancers
39. Nrf2
    K.M. Kim, Sung Hwan Ki · 2017 · Elsevier eBooks
40. Nrf2-Mediated Dichotomy in the Vascular System: Mechanistic and Therapeutic Perspective
    Wu, Weiwei, Hendrix, Andrew, Nair, Sharad, Cui, Taixing · 2022 · Cells
41. Schistosoma haematobium infection is associated with alterations in energy and purine-related metabolism in preschool-aged children
    Osakunor, Derick N. M., Mduluza, Takafira, Osei-Hyiaman, Douglas, Burgess, Karl, Woolhouse, Mark E. J., Mutapi, Francisca · 2020 · PLoS neglected tropical diseases
42. Natural flavonoids from herbs and nutraceuticals as ferroptosis inhibitors in central nervous system diseases: current preclinical evidence and future perspectives
    Qiuhe Li, Xiaohang Yang, Tiegang Li · 2025 · Frontiers in Pharmacology
43. Proteomics analysis of dendritic cell activation by contact allergens reveals possible biomarkers regulated by Nrf2
    Franz Mußotter, Janina Melanie Tomm, Zeina El Ali, Marc J. Pallardy, Saadia Kerdine‐Römer, Mario E. Götz, Martin von Bergen�, Andrea Haase, Andreas Luch · 2016 · Toxicology and Applied Pharmacology
44. p62 functions as a signal hub in metal carcinogenesis
    Zhuo Zhang, Max Costa · 2021 · Seminars in Cancer Biology
45. The Potential of Nrf2 Activation as a Therapeutic Target in Systemic Lupus Erythematosus
    Michelle T. Barati, Dawn J. Caster · 2022 · Metabolites
46. Heteroleptic Gold(I)-bisNHC complex with excellent activity in vitro, ex vivo and in vivo against endometrial cancer
    Qimeng Xiao, Yuan‐Hao Liu, Guizhi Jiang, Yuan Liu, Yan Huang, Wukun Liu, Zhenbo Zhang · 2022 · European Journal of Medicinal Chemistry
47. Spatial Analysis of NQO1 in Non-Small Cell Lung Cancer Shows Its Expression Is Independent of NRF1 and NRF2 in the Tumor Microenvironment
    Boback Kaghazchi, In Hwa Um, Mustafa Elshani, Oliver J. Read, David James Harrison · 2022 · Biomolecules
48. DKK1‐CKAP4 signal axis promotes hepatocellular carcinoma aggressiveness
    Kosuke Iguchi, Ryota Sada, Shinji Matsumoto, Hirokazu Kimura, Yoh Zen, Masayuki Akita, Hidetoshi Gon, Takumi Fukumoto, Akira Kikuchi · 2023 · Cancer Science
49. CRISPR activation screens identify the SWI/SNF ATPases as suppressors of ferroptosis
    Kamakoti P. Bhat, Jinchu Vijay, Caroline K. Vilas, Jyoti Asundi, Jun Zou, Ted Lau, Xiaoyu Tracy Cai, Musaddeque Ahmed, Michał Kabza, Julie Weng et al. · 2024 · Cell Reports
50. The greedy nature of mutant RAS: a boon for drug discovery targeting cancer metabolism?
    Jing Lv, Jieqiong Wang, Siyu Chang, Mingyao Liu, Xiufeng Pang · 2015 · Acta Biochimica et Biophysica Sinica
51. The anti-oxidative transcription factor Nuclear factor E2 related factor-2 (Nrf2) counteracts TGF-β1 mediated growth inhibition of pancreatic ductal epithelial cells -Nrf2 as determinant of pro-tumorigenic functions of TGF-β1
    Geeske Genrich, Marcus Kruppa, Lennart Lenk, Ole Helm, Anna Broich, Sandra Freitag‐Wolf, Christoph Röcken, Bence Sipos, H. Schäfer, Susanne Sebens · 2016 · BMC Cancer
52. Nrf2 and AhR in metabolic reprogramming after contaminant exposure
    Sylvie Bortoli, Elisa A. Boutet-Robinet, Dominique Lagadic‐Gossmann, Laurence Therese HUC · 2017 · Current Opinion in Toxicology
53. Connecting the Dots in the Neuroglobin-Protein Interaction Network of an Unstressed and Ferroptotic Cell Death Neuroblastoma Model
    Zoë P. Van Acker, Geert A. Van Raemdonck, Emilie Logie, Sara Ilse Van Acker, Geert Baggerman, Wim Vanden Berghe, Peter Ponsaerts, Sylvia Dewilde · 2019 · Cells
54. The Role of Macroautophagy and Chaperone-Mediated Autophagy in the Pathogenesis and Management of Hepatocellular Carcinoma
    Anastasia D. Karampa, ANNA C. GOUSSIA, Georgios K. Glantzounis, Eleftheria M. Mastoridou, Nikolaos-Andreas Anastasopoulos, Antonia V. Charchanti · 2022 · Cancers
55. Melanocortin 1 receptor activation protects against alpha-synuclein pathologies in models of Parkinson’s disease
    Waijiao Cai, Pranay Srivastava, Danielle D. Feng, Yue Lin, Charles R. Vanderburg, Yuehang Xu, Pamela J. McLean, Matthew P. Frosch, David E. Fisher, Michael A. Schwarzschild et al. · 2022 · Molecular Neurodegeneration
56. Lowering Endogenous Cathepsin D Abundance Results in Reactive Oxygen Species Accumulation and Cell Senescence
    Siyuan Su, Xu Zhu, Liang Lin, Xianwei Chen, Yang Wang, Jin Zi, Yusheng Dong, Yingying Xie, Ying‐Hui Zhu, Ju Zhang et al. · 2015 · Molecular & Cellular Proteomics
57. NRF2 signaling in cytoprotection and metabolism
    Shohei Murakami, Yusuke Kusano, Keito Okazaki, Takaaki Akaike, Hozumi Motohashi · 2023
58. Mechanisms of alveolar type II epithelial cells’ mitochondrial quality control during acute lung injury/acute respiratory distress syndrome: bridging the gap between oxidative stress, inflammation, and fibrosis
    Lin Zeng, Jiangtian Yan · 2025 · Frontiers in Physiology
59. Glucose transporter 1 is important for the glycolytic metabolism of human endometrial stromal cells in hypoxic environment
    Takeharu Kido, Hiromi Murata, Akemi Nishigaki, Hiroaki Tsubokura, Shinnosuke Komiya, Naoko Kida, Maiko Kakita‐Kobayashi, Yoji Hisamatsu, 朋子 都築, Yoshiko Katoh Hashimoto et al. · 2020 · Heliyon
60. High Transaldolase 1 expression predicts poor survival of patients with upper tract urothelial carcinoma
    Yiru Wu, Yi‐Chen Lee, Wei‐Ming Li, Wei‐Chi Hsu, Hui‐Hui Lin, Lin‐Li Chang, A‐Mei Huang, Jhen‐Hao Jhan, Wen‐Jeng Wu, Ching‐Chia Li et al. · 2021 · Pathology International
61. Interplay between nuclear factor erythroid 2-related factor 2 and inflammatory mediators in COVID-19-related liver injury
    Dandan Zhu, Xuemei Tan, Liqing Lu, Sijia Yu, Ru-Li Jian, Xinfang Liang, Yi-Xuan Liao, Wei Fan, Lucíia Barbier-Torres, Austin Yang et al. · 2021 · World Journal of Gastroenterology
62. A CRISPR screen identifies redox vulnerabilities for KEAP1/NRF2 mutant non-small cell lung cancer
    Chang Jiang, Nathan P. Ward, Nicolas Prieto-Farigua, Yun Pyo Kang, Anish Thalakola, Mingxiang Teng, Gina M. DeNicola · 2022 · Redox Biology
63. Therapeutic Targeting of Glutaminolysis as a Novel Strategy to Combat Cancer Stem Cells
    Ting‐Wan Kao, Yao-Chen Chuang, Hsin‐Lun Lee, Chia‐Chun Kuo, Yao Shen · 2022 · International Journal of Molecular Sciences
64. Nuclear Factor Erythroid 2 Related Factor 2 and Mitochondria Form a Mutually Regulating Circuit in the Prevention and Treatment of Metabolic Syndrome
    Jiawei Zhang, Weiqiang Lv, Guanfei Zhang, Mengqi Zeng, Wenli Cao, Jiacan Su, Ke Jiang Cao, Jiankang Liu · 2024 · Antioxidants and Redox Signaling
65. Transcription Factor NRF2 in Shaping Myeloid Cell Differentiation and Function
    Marc Pfefferlé, Florence Vallelian · 2024 · Advances in experimental medicine and biology
66. The role of DGAT1 and DGAT2 in tumor progression via fatty acid metabolism: A comprehensive review
    Leisheng Wang, Shiwei Xu, Mengzhen Zhou, Hao Hu, Jinyou Li · 2024 · International Journal of Biological Macromolecules
67. Sustained NRF2 activation in hereditary leiomyomatosis and renal cell cancer (HLRCC) and in hereditary tyrosinemia type 1 (HT1)
    Ivraj Singh Sandhu, Nicholas James Maksim, Eva A. Amouzougan, Bryce Wilson Gallion, Anthony L.J. Raviele, Aikseng Ooi · 2015 · Biochemical Society Transactions
68. NAD(P)H:Quinone Oxidoreductase-1 Expression Sensitizes Malignant Melanoma Cells to the HSP90 Inhibitor 17-AAG
    Shuya Kasai, Nobuyuki Arakawa, Ayaka Okubo · 2016 · PLoS ONE
69. Regulation of the CNC-bZIP transcription factor Nrf2 by Keap1 and the axis between GSK-3 and β-TrCP
    John D. Hayes, Kimimuepigha Ebisine, Ritu S. Sharma, Sudhir Chowdhry, Albena T. Dinkova‐Kostova, Calum D. Sutherland · 2016 · Current Opinion in Toxicology
70. Dual effects of the Nrf2 inhibitor for inhibition of hepatitis C virus and hepatic cancer cells
    Y. Murakami, K. Sugiyama, H. Ebinuma, N. Nakamoto, Keisuke Ojiro, Po-Sung Chu, N. Taniki, Yoshimasa Saito, Toshiaki Teratani, Yuzo Koda et al. · 2018 · BMC Cancer
71. Challenges facing nanotoxicology and nanomedicine due to cellular diversity
    Mohd Javed Akhtar, Maqusood Ahamed, Hisham A. Alhadlaq · 2018 · Clinica Chimica Acta
72. Radical Stress Is More Cytotoxic in the Nucleus than in Other Organelles
    Laurent M. Paardekooper, Ellen van Vroonhoven, Martin ter Beest, Geert van den Bogaart · 2019 · International Journal of Molecular Sciences
73. Targeting NRF2 to suppress ferroptosis in brain injury.
    Shunchen Song, Yaxuan Gao, Yi Sheng, Tongyu Rui, Chengliang Luo · 2021 · PubMed
74. NRF2 Mediates Therapeutic Resistance to Chemoradiation in Colorectal Cancer through a Metabolic Switch
    Sean Michael O'Cathail, Chieh‐Hsi Wu, Rachael J. Thomas, M. Hawkins, Tim Maughan, Annabelle Lewis · 2021 · Antioxidants
75. The complex interplay between redox dysregulation and mTOR signaling pathway in cancer: A rationale for cancer treatment
    Christophe Glorieux, Cinthya Enriquez-Lara, Pedro Buc Calderón · 2024 · Biochemical Pharmacology
76. Nuclear Factor Erythroid 2–Related Factor 2 Depletion Sensitizes Pancreatic Cancer Cells to Gemcitabine via Aldehyde Dehydrogenase 3a1 Repression
    Ryotaro Matsumoto, Shin Hamada, Yu Tanaka, Keiko Taguchi, Masayuki P. Yamamoto, Atsushi Masamune · 2021 · Journal of Pharmacology and Experimental Therapeutics
77. Impact of Nuclear Factor Erythroid 2–Related Factor 2 in Hepatocellular Carcinoma: Cancer Metabolism and Immune Status
    Norifumi Iseda, Shinji Itoh, Tomoharu Yoshizumi, Takahiro Tomiyama, Akinari Morinaga, Kyohei Yugawa, Masahiro Shimokawa, Tomonari Shimagaki, Huanlin Wang, Takeshi Kurihara et al. · 2021 · Hepatology Communications
78. Dissecting Flux Balances to Measure Energetic Costs in Cell Biology: Techniques and Challenges
    Easun Arunachalam, William T. Ireland, Xingbo Yang, Daniel J. Needleman · 2022 · Annual Review of Condensed Matter Physics
79. NRF2 and the Moirai: Life and Death Decisions on Cell Fates
    Yoko Yagishita, Dionysios V. Chartoumpekis, Thomas W. Kensler, Nobunao Wakabayashi · 2022 · Antioxidants and Redox Signaling
80. Ferroptosis, Acyl Starvation, and Breast Cancer
    Rafał Bobiński, Mieczysław Dutka, Monika Pizon, Wioletta Waksmańska, Anna Pielesz · 2022 · Molecular Pharmacology
81. Ferroptosis: potential targets and emerging roles in pancreatic diseases
    Zijian Huang, Yuan Ma, Zhiguo Sun, Long Cheng, Gang Wang · 2023 · Archives of Toxicology
82. Exploring the multifaceted role of NRF2 in brain physiology and cancer: A comprehensive review
    Maya M. Moubarak, Antonio C. Pagano Zottola, Claire M. Larrieu, Sylvain Cuvellier, Thomas Daubon, Océane C. B. Martin · 2023 · Neuro-Oncology Advances
83. Differential squamous cell fates elicited by NRF2 gain of function versus KEAP1 loss of function
    Jun A. Takahashi, Takafumi Suzuki, Miu Sato, Shuji Nitta, Nahoko Yaguchi, Tatsuki Muta, Kouhei Tsuchida, Hiromi Suda, Masanobu Morita, Shin Hamada et al. · 2024 · Cell Reports
84. Calcium signals as regulators of ferroptosis in cancer
    Ioana Stejerean‐Todoran, Christine Silvia Gibhardt, Ivan Bogeski · 2024 · Cell Calcium
85. NADPH Oxidase 4 at the Nexus of Diabetes, Reactive Oxygen Species, and Renal Metabolism
    Eugene P. Rhee · 2015 · Journal of the American Society of Nephrology
86. Benzo[a]pyrene affects Jurkat T cells in the activated state via the antioxidant response element dependent Nrf2 pathway leading to decreased IL-2 secretion and redirecting glutamine metabolism
    Jayaseelan Murugaiyan, Maxie Rockstroh, Juliane Wagner, Sven Baumann, Katrin Schorsch, Saskia Trump, Irina Lehmann, Martin von Bergen�, Janina Melanie Tomm · 2013 · Toxicology and Applied Pharmacology
87. Trk-fused gene (TFG) regulates pancreatic β cell mass and insulin secretory activity
    Takeshi Yamamotoya, Yusuke Nakatsu, Akifumi Kushiyama, Yasuka Matsunaga, Koji Ueda, Yuki Inoue, Masakí Inoue, Hideyuki Sakoda, Midori Fujishiro, Hiraku Ono et al. · 2017 · Scientific Reports
88. The Intricate Metabolism of Pancreatic Cancers
    Felipe Camelo, Anne Le · 2018 · Advances in experimental medicine and biology
89. Targeting Metabolic Bottlenecks in Lung Cancer
    Volkan I. Sayin, Sarah E. LeBoeuf, Thales Y. Papagiannakopoulos · 2019 · Trends in cancer
90. Distinct Mechanisms Are Responsible for Nrf2-Keap1 Pathway Activation at Different Stages of Rat Hepatocarcinogenesis
    Claudia Orrù, Andrea Perra, Marta Anna Kowalik, Sabrina Rizzolio, Elisabetta Puliga, Lavinia Cabras, Silvia Giordano, Amedeo Columbano · 2020 · Cancers
91. TCF11 Has a Potent Tumor-Repressing Effect Than Its Prototypic Nrf1α by Definition of Both Similar Yet Different Regulatory Profiles, With a Striking Disparity From Nrf2
    Meng Wang, Yonggang Ren, Shaofan Hu, Keli Liu, Lu Qiu, Yiguo Zhang · 2021 · Frontiers in Oncology
92. NRF2 Regulates HER2 and HER3 Signaling Pathway to Modulate Sensitivity to Targeted Immunotherapies
    Hilal S. Khalil, Simon P. Langdon, Ibrahim Hamza Kankia, James Bown, Yusuf Deeni · 2015 · Oxidative Medicine and Cellular Longevity
93. Dual Biological Functions of a Cytoprotective Effect and Apoptosis Induction by Bioavailable Marine Carotenoid Fucoxanthinol through Modulation of the Nrf2 Activation in RAW264.7 Macrophage Cells
    Junsei Taira, Miki Sonamoto, Masatsugu Uehara · 2017 · Marine Drugs
94. Mechanisms of NRF2 activation to mediate fetal hemoglobin induction and protection against oxidative stress in sickle cell disease
    Xingguo Zhu, Aluya Oseghale, Lopez H Nicole, Yaqin Li, Betty S. Pace · 2019 · Experimental Biology and Medicine
95. KEAP1-NRF2 Interaction in Cancer: Competitive Interactors and Their Role in Carcinogenesis
    Marina Oskomić, Antonija Tomić, Lea Barbarić, Antonia Matić, Domagoj C. Kindl, Mihaela Matovina · 2025 · Cancers
96. Distinct roles for the thioredoxin and glutathione antioxidant systems in Nrf2-Mediated lung tumor initiation and progression
    Amanda Sherwood, Basma A. Yasseen, Janine M. DeBlasi, Samantha Caldwell, Gina M. DeNicola · 2025 · Redox Biology
97. Metabolic remodeling by RNA polymerase gene mutations is associated with reduced β-lactam susceptibility in oxacillin-susceptible MRSA
    Shinya Watanabe, Chijioke Adulberth Nsofor, Kanate Thitiananpakorn, Xin-Ee Tan, Yoshifumi Aiba, Remi Takenouchi, Kotaro Kiga, Teppei Sasahara, Kazuhiko Miyanaga, Srivani Veeranarayanan et al. · 2024 · mBio
98. A small molecule targeting glutathione activates Nrf2 and inhibits cancer cell growth through promoting Keap-1 S -glutathionylation and inducing apoptosis
    Lihong Wang, Guojing Qu, Yuandi Gao, Le Su, Qing Ye, Fan Jiang, Bao‐Xiang Zhao, Jun‐Ying Miao · 2018 · RSC Advances
99. The antioxidant transcription factor Nrf2 modulates the stress response and phenotype of malignant as well as premalignant pancreatic ductal epithelial cells by inducing expression of the ATF3 splicing variant ΔZip2
    My-Lan Pianka, Lisa Hesse, Florian Deisinger, Bence Sipos, Christoph Röcken, Alexander Arlt, Susanne Sebens, Ole Helm, H. Schäfer · 2018 · Oncogene
100. Perspectives of TrxR1-based cancer therapies
     Elias S.J. Arnér · 2019 · Elsevier eBooks